Avanos Medical, Inc. (AVNS) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 0 | 28.2M | 14M | 6.8M | 25.7M | 57.9M | 23M | 27.8M | -8M | 12.7M | 29.1M | -2.6M |
| Operating CF Margin % | - | 15.59% | 7.87% | 3.89% | 15.34% | 32.24% | 13.5% | 16.19% | -4.82% | 7.33% | 16.99% | -1.53% |
| Operating CF Growth % | -100% | -51.3% | -39.13% | -75.54% | 421.25% | 355.91% | -20.96% | 1169.23% | -17.65% | -62.31% | 2.46% | -109.63% |
| Net Income | 0 | -1.3M | -1.4M | -76.8M | 6.6M | -397.3M | 4.3M | 1.8M | -900K | 11M | -3.7M | -68.1M |
| Depreciation & Amortization | 0 | 9.9M | 9.4M | 10M | 9.6M | 11.1M | 11.7M | 11.3M | 11.4M | 11.5M | 11M | 11.5M |
| Stock-Based Compensation | 0 | 0 | 3.5M | 4.1M | 3.8M | 3.8M | 2.6M | 3.8M | 3.6M | 4M | 3.9M | 3.9M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6.6M | 0 | 0 |
| Other Non-Cash Items | 32.4M | 4.8M | 5.4M | 76.3M | 300K | 395.3M | 700K | 2.6M | 300K | -3.8M | -2.7M | 63.5M |
| Working Capital Changes | -32.4M | 14.8M | -2.9M | -6.8M | 5.4M | 45M | 3.7M | 8.3M | -22.4M | -3.4M | 20.6M | -13.4M |
| Change in Receivables | 0 | 8.1M | 700K | -3M | 25.1M | 300K | -7.7M | -7.4M | 8.2M | 9M | 11.1M | -7.3M |
| Change in Inventory | 0 | 2.8M | -500K | -3.3M | 1.2M | 44.9M | 1.9M | -3.1M | -4.7M | 11.3M | 6.5M | -4.5M |
| Change in Payables | 0 | 1.1M | 1.1M | 4.8M | -6.4M | 300K | -1.2M | -2.3M | 2.3M | 1.6M | -14.2M | 6.1M |
| Cash from Investing | 0 | -6.8M | -31.5M | -13.2M | -9.1M | -7.6M | -12M | -5.9M | -2M | 81M | -48.9M | -6.5M |
| Capital Expenditures | 0 | -6.9M | -7M | -11M | -6.7M | -4.8M | -3M | -5.9M | -4.1M | -5.9M | -3.9M | -4M |
| CapEx % of Revenue | - | 3.81% | 3.94% | 6.29% | 4% | 2.67% | 1.76% | 3.44% | 2.47% | 3.4% | 2.28% | 2.36% |
| Acquisitions | -3.4M | 300K | 0 | -2.2M | -2.4M | 0 | 0 | 0 | 2.1M | 86.9M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 3.4M | -200K | -24.5M | 0 | 0 | -2.8M | -9M | 0 | 0 | 0 | -45M | -2.5M |
| Cash from Financing | 0 | -2.7M | -2M | -3.2M | -29.1M | -27.4M | -16M | -5M | -700K | -114.7M | 46.7M | -4.1M |
| Debt Issued (Net) | -2.3M | -2.4M | -2.3M | -2.4M | -27.3M | -27.3M | -13.2M | -1.5M | 8.4M | -96.6M | 55M | -1.5M |
| Equity Issued (Net) | 0 | -300K | 300K | -800K | -2.2M | -100K | -100K | -3.5M | -9.1M | -6.4M | -9.2M | -2.6M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -300K | 0 | -800K | -2.2M | -100K | -100K | -3.5M | -9.1M | -6.2M | -9.2M | -2.6M |
| Other Financing | 2.3M | 0 | 0 | 0 | 400K | 0 | -2.7M | 0 | 0 | -11.7M | 900K | 0 |
| Net Change in Cash | -24.2M | 19.3M | -19.8M | -6.7M | -10.7M | 18.7M | -3.2M | 16.4M | -11.9M | -19.4M | 25.3M | -13.9M |
| Free Cash Flow | 0 | 21.3M | 7M | -4.2M | 19M | 53.1M | 20M | 21.9M | -12.1M | 6.8M | 25.2M | -6.6M |
| FCF Margin % | - | 11.77% | 3.94% | -2.4% | 11.34% | 29.57% | 11.74% | 12.75% | -7.28% | 3.92% | 14.71% | -3.9% |
| FCF Growth % | -100% | -59.89% | -65% | -119.18% | 257.02% | 680.88% | -20.63% | 431.82% | -12.04% | -76.39% | 9.09% | -128.82% |
| FCF per Share | - | 0.46 | 0.15 | -0.09 | 0.41 | 1.15 | 0.43 | 0.47 | -0.26 | 0.15 | 0.54 | -0.14 |
| FCF Conversion (FCF/Net Income) | - | 7.62x | -10.00x | -0.09x | 3.89x | -0.15x | 5.35x | 15.44x | 8.89x | 1.21x | -7.86x | 0.04x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |